Centrum 7/6  banner

prescription drug rebates in Medicare Part D

PCMA issues statement on HHS report on Rx drug rebates

PCMA issues statement on HHS report on Rx drug rebates

WASHINGTON — Pharmaceutical Care Management Association (PCMA) president and chief executive officer JC Scott issued the following statement on the Health and Human Services Officer of Inspector General report (OIG) on prescription drug rebates in Medicare Part D. “Today’s OIG report further dispels the false narrative about PBM-negotiated rebates and confirms that rebates lead to lower prescription

PP_1170x120_10-25-21